Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
18-Feb-2026 | 489.95 | 504 | 485.3 | 487.85 | 12,086 | 21,25,91,564.25 | 1,41,864 |
19-Feb-2026 | 493.9 | 506 | 482.05 | 487.5 | 16,063 | 22,83,74,866.35 | 1,42,425 |
20-Feb-2026 | 483 | 486 | 477.4 | 478.35 | 5,634 | 7,44,61,656.25 | 62,310 |
23-Feb-2026 | 480.1 | 482.9 | 468.9 | 474.45 | 6,094 | 6,29,20,892 | 62,464 |
24-Feb-2026 | 474 | 485 | 471 | 483.7 | 8,558 | 8,18,11,736.45 | 85,377 |
25-Feb-2026 | 483.7 | 489.4 | 475 | 478.65 | 7,556 | 6,58,82,598.9 | 64,643 |
26-Feb-2026 | 478.9 | 489.95 | 478.9 | 482.25 | 4,006 | 4,43,09,731.2 | 47,657 |
27-Feb-2026 | 481.1 | 492.95 | 477.2 | 488.15 | 7,706 | 6,78,82,740.4 | 73,188 |
02-Mar-2026 | 472 | 482.25 | 469.7 | 474.45 | 6,411 | 6,22,05,522.5 | 64,884 |
04-Mar-2026 | 466.65 | 470 | 460.1 | 467.2 | 7,277 | 6,26,82,357.55 | 72,086 |
05-Mar-2026 | 468.1 | 489 | 468.1 | 483 | 5,158 | 5,07,13,117.15 | 59,677 |
06-Mar-2026 | 485.25 | 485.45 | 472.2 | 474.35 | 3,082 | 2,71,83,466.9 | 31,271 |
09-Mar-2026 | 474.3 | 480.75 | 457.1 | 479.6 | 9,363 | 7,18,20,772.5 | 69,430 |
10-Mar-2026 | 479.6 | 503 | 479.6 | 500.6 | 11,490 | 13,17,39,710.75 | 1,46,222 |
11-Mar-2026 | 503.9 | 515 | 494 | 507.25 | 11,347 | 16,91,22,518.2 | 1,37,264 |
12-Mar-2026 | 507.2 | 507.25 | 493.2 | 498.95 | 7,392 | 8,99,80,204.45 | 75,945 |
13-Mar-2026 | 497.9 | 497.9 | 468 | 470.3 | 8,078 | 9,99,40,658.55 | 1,00,567 |
16-Mar-2026 | 468 | 481.15 | 461.4 | 463.7 | 8,782 | 6,37,42,693.2 | 51,841 |
17-Mar-2026 | 462 | 472 | 456.55 | 463.85 | 8,319 | 6,93,38,843.65 | 71,932 |
18-Mar-2026 | 463 | 485 | 463 | 481.3 | 4,689 | 4,49,55,379.4 | 43,566 |
19-Mar-2026 | 477 | 477 | 464.85 | 468.2 | 8,172 | 4,07,63,719.05 | 48,786 |
The organisation is the largest CDMO serving the Indian pharmaceutical industry, with a proven track record and a broad clientele.
The IPO comprised a fresh issue of shares worth ₹680 crore and an offer-for-sale (OFS) of 1.73 crore shares, aggregating ₹1,177 crore.
The IPO consists of a fresh issue of ₹680 crore and an offer for sale (OFS) of up to 1.73 crore shares at a face value of ₹2 each.
On Monday, the business said that it had received ₹829 crore from anchor investors ahead of the public share sale subscription period.
The IPO includes a new issue of 1 Crore shares worth ₹680.00 Crore and an offer for sale of 1.73 Crore shares worth ₹1,176.74 Crore.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
